These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 11045151

  • 1. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
    Tóthová E, Nebesnáková E, Kafková A, Stecová N, Fricová M.
    Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
    [Abstract] [Full Text] [Related]

  • 2. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E, Fricová M, Stecová N, Hlebasková M, Kafková A, Raffac S, Guman T, Svorcová E, Nebesnáková E.
    Neoplasma; 2001 Aug; 48(5):389-92. PubMed ID: 11845984
    [Abstract] [Full Text] [Related]

  • 3. [Successful treatment with interferon-alpha in a case of acute myeloid leukemia with del (20q) following polycythemia vera].
    Sumi M, Tauchi T, Takaku T, Ohyashiki JH, Ohyashiki K.
    Rinsho Ketsueki; 2005 Nov; 46(11):1208-12. PubMed ID: 16440805
    [Abstract] [Full Text] [Related]

  • 4. Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
    Cacciola E, Cacciola RR, Guglielmo P, Stagno F, Giustolisi R.
    Haematologica; 1999 Aug; 84(8):755-6. PubMed ID: 10457418
    [No Abstract] [Full Text] [Related]

  • 5. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B, Rödjer S, Westin J.
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [Abstract] [Full Text] [Related]

  • 6. Long-term management of polycythemia vera with hydroxyurea: a progress report.
    Kaplan ME, Mack K, Goldberg JD, Donovan PB, Berk PD, Wasserman LR.
    Semin Hematol; 1986 Jul; 23(3):167-71. PubMed ID: 3749925
    [No Abstract] [Full Text] [Related]

  • 7. Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.
    Ellis AK, Lee DH.
    Am J Hematol; 2002 Nov; 71(3):237-8. PubMed ID: 12410589
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR.
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [Abstract] [Full Text] [Related]

  • 9. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
    Oskay T, Kutluay L, Ozyilkan O.
    Eur J Dermatol; 2002 Apr; 12(6):586-8. PubMed ID: 12459535
    [Abstract] [Full Text] [Related]

  • 10. Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
    Kiladjian JJ, Chevret S, Dosquet C, Chomienne C, Rain JD.
    J Clin Oncol; 2011 Oct 10; 29(29):3907-13. PubMed ID: 21911721
    [Abstract] [Full Text] [Related]

  • 11. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
    Alvarez-Larrán A, Martínez-Avilés L, Hernández-Boluda JC, Ferrer-Marín F, Antelo ML, Burgaleta C, Mata MI, Xicoy B, Martínez-Trillos A, Gómez-Casares MT, Durán MA, Marcote B, Ancochea A, Senín A, Angona A, Gómez M, Vicente V, Cervantes F, Bellosillo B, Besses C.
    Ann Hematol; 2014 Dec 10; 93(12):2037-43. PubMed ID: 24981691
    [Abstract] [Full Text] [Related]

  • 12. Oral squamous cell carcinoma during long-term treatment with hydroxyurea.
    De Benedittis M, Petruzzi M, Giardina C, Lo Muzio L, Favia G, Serpico R.
    Clin Exp Dermatol; 2004 Nov 10; 29(6):605-7. PubMed ID: 15550132
    [Abstract] [Full Text] [Related]

  • 13. Leukemic transformation in three patients with polycythemia vera. Analysis of the clinicopathological features and N-ras gene mutation.
    Sakai H, Karasawa M, Okamoto K, Maehara T, Tsukamoto N, Murakami H, Naruse T, Morita K, Tsuchiya J.
    J Med; 1996 Nov 10; 27(3-4):183-91. PubMed ID: 8982966
    [Abstract] [Full Text] [Related]

  • 14. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
    Boivin P.
    Nouv Rev Fr Hematol (1978); 1993 Nov 10; 35(5):491-8. PubMed ID: 8295823
    [Abstract] [Full Text] [Related]

  • 15. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
    Tiziana Storlazzi C, Pieri L, Paoli C, Daniele G, Lasho T, Tefferi A, Vannucchi AM.
    Am J Hematol; 2014 Apr 10; 89(4):438-42. PubMed ID: 24382738
    [Abstract] [Full Text] [Related]

  • 16. Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera.
    Dastugue N, Pris J, Colombies P.
    Cancer Genet Cytogenet; 1990 Feb 10; 44(2):275-6. PubMed ID: 2297687
    [Abstract] [Full Text] [Related]

  • 17. Eosinophilic leukemic transformation in polycythemia rubra vera (PRV).
    Chim CS, Ma SK.
    Leuk Lymphoma; 2005 Mar 10; 46(3):447-50. PubMed ID: 15621837
    [Abstract] [Full Text] [Related]

  • 18. Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea.
    Pulik M, Lionnet F, Genet P, Petitdidier C, Jary L, Touahri T.
    Am J Hematol; 1996 Nov 10; 53(3):207-8. PubMed ID: 8895700
    [No Abstract] [Full Text] [Related]

  • 19. Hypereosinophilic syndrome associated with polycythemia vera.
    Varon D, Wetzler M, Berrebi A.
    Arch Intern Med; 1986 Jul 10; 146(7):1440-1. PubMed ID: 3718142
    [Abstract] [Full Text] [Related]

  • 20. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM, Mack K, Kaplan ME, Peterson P, Berk PD, Wasserman LR.
    Semin Hematol; 1997 Jan 10; 34(1):17-23. PubMed ID: 9025158
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.